- $2.94bn
- $2.81bn
- $609.86m
- 66
- 53
- 87
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 282 | 307 | 316 | 374 | 424 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 274 | 244 | 324 | 364 | 417 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 170 | 124 | 208 | 237 | 270 |
Provision for Income Taxes | |||||
Net Income After Taxes | 135 | 99.6 | 168 | 193 | 212 |
Net Income Before Extraordinary Items | |||||
Net Income | 135 | 99.6 | 168 | 193 | 212 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 135 | 99.6 | 168 | 193 | 212 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.05 | 3 | 4.97 | 5.76 | 6.31 |
Dividends per Share |